This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Kellogg's (K) Q3 Earnings Upcoming: Here's All You Should Note
by Zacks Equity Research
Kellogg's (K) third-quarter 2022 results are likely to reflect gains from the company's revenue growth management actions, whereas cost inflation and supply-chain bottlenecks are likely to have been a concern.
Sysco's (SYY) Q1 Earnings Upcoming: Key Factors to Note
by Zacks Equity Research
Sysco's (SYY) first-quarter fiscal 2023 results are likely to reflect gains from the Recipe for Growth program and a diversified model, whereas high costs might have been a concern.
Service Corporation (SCI) to Report Q3 Earnings: Things to Note
by Zacks Equity Research
Service Corporation's (SCI) third-quarter 2022 performance will likely reflect the adverse impact of rising inflationary pressure. Strength in the funeral segment has been an upside.
Stock & ETF Treats for This Halloween
by Sanghamitra Saha
Per NRF, participation in Halloween-related activities will bounce back to pre-pandemic levels this year.
Hershey (HSY) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Hershey (HSY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors Likely to Influence Molson Coors' (TAP) Earnings in Q3
by Zacks Equity Research
Molson Coors' (TAP) Q3 results are likely to reflect gains from positive pricing and favorable brand and channel mix stemming from portfolio premiumization and reduced on-premise channel restrictions.
Here's Why Clorox (CLX) is Poised to Top Q1 Earnings Estimates
by Zacks Equity Research
Clorox's (CLX) first-quarter fiscal 2023 results are likely to reflect gains from the IGNITE strategy and pricing actions, whereas elevated inflation concerns are likely to have acted as deterrents.
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Mondelez's (MDLZ) Q3 Earnings Upcoming: Key Things to Note
by Zacks Equity Research
Mondelez's (MDLZ) third-quarter 2022 results are likely to reflect gains from buyouts, whereas input cost inflation and supply-chain woes are likely to have been a concern.
Church & Dwight (CHD) Q3 Earnings Upcoming: Key Things to Note
by Zacks Equity Research
Church & Dwight's (CHD) third-quarter 2022 results are likely to reflect raw material cost inflation, high SG&A expenses and a slowdown in discretionary brands, while pricing actions are likely to have been an upside.
Can Colgate (CL) Beat Q3 Earnings Estimates Amid Cost Woes?
by Zacks Equity Research
Colgate's (CL) Q3 results are expected to reflect gains from strong demand, brand strength, innovation and digital growth, offset by higher raw material and logistic costs.
Altria's (MO) Q3 Earnings Upcoming: Key Factors to Note
by Zacks Equity Research
Altria's (MO) third-quarter 2022 results are likely to reflect gains from pricing and strength in the oral tobacco products space, while cost inflation may have been a concern.
Will Pricing Aid Keurig's (KDP) Q3 Earnings Amid Cost Woes?
by Zacks Equity Research
A recovery in the supply chain of coffee and non-carbonated beverages, pricing gains to mitigate inflation, and continued portfolio growth are likely to aid Keurig's (KDP) Q3 results amid cost woes.
Hershey (HSY) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Hershey (HSY) closed at $228.22 in the latest trading session, marking a +1.55% move from the prior day.
Why Hershey (HSY) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Hershey (HSY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Simply Good Foods (SMPL) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Simply Good Foods (SMPL) delivered earnings and revenue surprises of 24.14% and 5.62%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?
Hershey (HSY) Stock Moves -0.46%: What You Should Know
by Zacks Equity Research
Hershey (HSY) closed the most recent trading day at $226.26, moving -0.46% from the previous trading session.
Beyond Meat (BYND) to Cut Workforce, Slashes 2022 Revenue View
by Zacks Equity Research
Beyond Meat (BYND) lowers 2022 revenue guidance amid rising inflation and increased competition. Also, the company unveils plans to cut the workforce.
Lamb Weston (LW) Stock Up More Than 15% in 3 Months: Here's Why
by Zacks Equity Research
Lamb Weston (LW) is benefiting from effective pricing actions. The company's efforts to boost production capacity and fuel long-term growth are noteworthy.
Hershey (HSY) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Hershey (HSY) closed at $227.80 in the latest trading session, marking a +1.46% move from the prior day.
The Estee Lauder Companies (EL) Rides on Robust Skin Care Unit
by Zacks Equity Research
The Estee Lauder Companies (EL) boasts a solid Skin Care portfolio, which has been aiding growth. The company is benefiting from a strong online business.
4 Defensive Bets to Pacify Pessimists to Ride Market Storms
by Snehadri Nag
Here we mention four defensive stocks, namely Lamb Weston (LW), Consolidated Water, McKesson and Hershey with strong prospects to stay afloat in the bear market.
Hershey (HSY) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Hershey (HSY) closed at $223.55, marking a +1.37% move from the previous day.
Inter Parfums' (IPAR) Brand Strength & Alliances Bode Well
by Zacks Equity Research
Inter Parfums (IPAR) benefits from the impressive performance of its brands. The company is expanding its business through new licenses or acquisitions.
Nu Skin's (NUS) Focus on Nu Vision 2025 & Product Launches Aids
by Zacks Equity Research
Nu Skin (NUS) is optimistic about its Nu Vision 2025 strategy to become the world's leading integrated beauty and wellness company, driven by a dynamic affiliate opportunity platform.